Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma

Annals of Oncology 2026

View at publisher
Authors: Yukun Chen, Y. Jin, Y.K. Chen, C. Cui, J. Yao, Y. T. Zhang, M. H. Li, G. F. Cao, S. Yang, Y. H. Fan, J. Y. Shi, X. Y. Zhang
+51 more L. Shen, Y. Shu, C. Wang, T. Dai, T. Mao, X. L. Luo, X. Y. Zhang, H. Xie, J. H. Zou, R.H. Xu, Z.X. Wang, F. Wang, Long Chen, Zengqing Guo, Bo LIU, Hongming Pan, Shundong Cang, Yi Jiang, Yi-Xiang Wang, Min Ye, Zhendong Chen, Da Jiang, Qin Lin, Wei Ren, Junsheng Wang, Lin Wu, Yong Xu, Zhanhui Miao, Meili Sun, Conghua Xie, Ying Liu, Qifeng Wang, Lina Zhao, Qi Li, Canhong Huang, Ke Jiang, Kunyu Yang, Daojun Li, Yunpeng Liu, Zhitu Zhu, Rixin Chen, Liqun Jia, Wei Ming Li, Wangjun Liao, Hong-Xu Liu, Daiyuan Ma, Jie Ma, Yanru Qin, Zhihong Shi, Qichun Wei, Ke Xiao
DOI: 10.1016/j.annonc.2026.01.005
Cited by: 4
References: 50

Fields of Study & Subjects

Esophageal Cancer Research and Treatment Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations

Publication details

Journal / source
Annals of Oncology
Publisher
Elsevier BV
Volume
37
Issue
7
Pages
986–998
Publication date
20 January 2026
Language
EN